Parkinson's Disease Trial, By Invitation NCT06973018 Sponsor: Aniko Bartfai Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT06973018
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are currently enrolled in a community-based brain rehabilitation program in Stockholm, Sweden
  • People who have mild to moderate thinking or memory difficulties caused by a brain injury or a disease affecting the nervous system
  • People who score 21 or higher on a standard memory and thinking test called the MoCA
  • People who have a sufficient ability to speak and understand Swedish
  • People who have access to a device connected to the internet (such as a computer, tablet, or smartphone)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a serious and long-term psychiatric or behavioural condition, such as schizophrenia or a substance use disorder
  • People who have been diagnosed with, or are suspected of having, dementia
  • People who are experiencing homelessness or other unstable living situations that would make reliable internet access uncertain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Aniko Bartfai
Registry
ClinicalTrials.gov
Start date
2 May 2021
Est. completion
1 July 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Mayo Portland Adaptability Inventory - fourth edition (MPAI-4), Participation subscale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov